TRIENTINE WAYMADE 200 mg, gélule — flacon(s) polyéthylène haute densité (PEHD) de 100 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930261941
  • CIP7 3026194
  • CIS 61926055

What the source publishes

Holder
WAYMADE (PAYS-BAS)
Active ingredients
TRIENTINE, DICHLORHYDRATE DE TRIENTINE
Form
gélule
Package
flacon(s) polyéthylène haute densité (PEHD) de 100 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
Marketing status
Déclaration de commercialisation
Authorised on
2022-09-13
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930261941
{
  "cis": "61926055",
  "cip7": "3026194",
  "form": "gélule",
  "name": "TRIENTINE WAYMADE 200 mg, gélule — flacon(s) polyéthylène haute densité (PEHD) de 100 gélule(s)",
  "cip13": "3400930261941",
  "holder": "WAYMADE (PAYS-BAS)",
  "routes": [
    "orale"
  ],
  "holders": [
    "WAYMADE (PAYS-BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "1235.61",
  "authorisedOn": "2022-09-13",
  "compositions": [
    {
      "name": "TRIENTINE",
      "nature": "FT",
      "strength": "200 mg",
      "linkageNumber": "1",
      "substanceCode": "46223",
      "dosageReference": "un gélule",
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "DICHLORHYDRATE DE TRIENTINE",
      "nature": "SA",
      "strength": "300 mg",
      "linkageNumber": "1",
      "substanceCode": "58471",
      "dosageReference": "un gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "1234.59",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "TRIENTINE WAYMADE 200 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "flacon(s) polyéthylène haute densité (PEHD) de 100 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2023-07-06",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "TRIENTINE",
    "DICHLORHYDRATE DE TRIENTINE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription initiale hospitalière annuelle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930261941"